Showing results (201-210 of 258) with videos related to
Sort By:
Pageof 26
Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Impact of Acne Vulgaris and Sarecycline on Social/Emotional Functioning and Daily Activities: PROSES StudyEmmy Graber, Hilary E Baldwin, Richard G Fried, et al.Journal of Drugs in Dermatology : JDD|February 2, 2024
INDIVIDUAL ARTICLE: Sarecycline Improves Acne Severity, Symptoms, and Psychosocial Burden in Non-nodular Acne Vulgaris: PROSES StudyHilary E Baldwin, Emmy Graber, Julie C Harper, et al.JMIR Dermatology|December 13, 2023
Integrative Approaches to Sleep Management in Skin Disease: Systematic ReviewVishnutheertha A Kulkarni, Isaiah Mojica, Vahram Gamsarian, et al.Pediatric Dermatology|August 27, 2025
Early Evidence of Safety, Clinical Benefit, and Pharmacokinetics of Roflumilast Cream 0.3% Once Daily for Treatment of Mild or Moderate Plaque Psoriasis in Children Aged 2-11 YearsAdelaide A Hebert, Shireen V Guide, Vlada Groysman, et al.Pediatric Dermatology|March 31, 2018
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industryElaine C Siegfried, Jennifer C Jaworski, Lawrence F Eichenfield, et al.Journal of Drugs in Dermatology : JDD|April 3, 2008
Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjectsRobert Matheson, Steven Kempers, Debra Breneman, et al.JAAD International|August 19, 2021
Therapeutic education in atopic dermatitis: A position paper from the International Eczema CouncilLawrence F Eichenfield, Ayan Kusari, Allison M Han, et al.Seminars in Cutaneous Medicine and Surgery|September 13, 2017
Atopic dermatitis: skin care and topical therapiesDavid M Fleischer, Jeremy Udkoff, Jenna Borok, et al.Dermatitis : Contact, Atopic, Occupational, Drug|March 3, 2021
Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12- O -Tetradecanoylphorbol-13-Acetate-Induced Dermatitis Model in MiceChandler W Rundle, Hope R Rietcheck, Jalal Maghfour, et al.Pediatric Dermatology|March 8, 2026
Long-Term Safety and Efficacy of Once-Daily and Proactive Twice-Weekly Roflumilast Cream 0.05% for Mild-to-Moderate Atopic Dermatitis in Children Aged 2-5 Years From a 52-Week, Phase 3 Trial (INTEGUMENT-OLE)Lawrence F Eichenfield, Mercedes E Gonzalez, Mark Boguniewicz, et al.Pageof 26